BioCardia, Inc.

NasdaqCM:BCDA Stock Report

Market Cap: US$10.4m

BioCardia Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BCDA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Jul 26BuyUS$7,175Peter AltmanIndividual7,500US$0.97
08 Jul 26BuyUS$5,208Peter AltmanIndividual5,400US$0.96
23 Jun 26BuyUS$103,584Simon StertzerIndividual109,200US$1.00
18 Jun 26BuyUS$2,043Peter AltmanIndividual2,300US$0.96
09 Jun 26BuyUS$4,250Peter AltmanIndividual5,000US$0.85
20 May 26BuyUS$1,570Peter AltmanIndividual1,700US$0.95
18 May 26BuyUS$5,244Peter AltmanIndividual5,700US$0.92
15 May 26BuyUS$5,202Peter AltmanIndividual5,100US$1.02
29 Apr 26BuyUS$5,550Peter AltmanIndividual5,000US$1.11
21 Apr 26BuyUS$1,230Peter AltmanIndividual1,000US$1.23
25 Mar 26BuyUS$366Peter AltmanIndividual300US$1.22
24 Mar 26BuyUS$744Peter AltmanIndividual600US$1.24
04 Feb 26BuyUS$5,650Peter AltmanIndividual5,000US$1.13
21 Jan 26BuyUS$1,194Peter AltmanIndividual900US$1.34
17 Dec 25BuyUS$1,170Peter AltmanIndividual900US$1.30
16 Dec 25BuyUS$274Peter AltmanIndividual200US$1.37
19 Sep 25BuyUS$60,000Peter AltmanIndividual48,000US$1.25
19 Sep 25BuyUS$360,000Andrew BlankIndividual288,000US$1.25
19 Sep 25BuyUS$498,000Simon StertzerIndividual398,400US$1.25
22 Aug 25BuyUS$1,281Peter AltmanIndividual700US$1.83
13 Aug 25BuyUS$183Peter AltmanIndividual100US$1.83
12 Aug 25BuyUS$700Peter AltmanIndividual400US$1.75
11 Aug 25BuyUS$2,989Peter AltmanIndividual1,700US$1.76

Insider Trading Volume

Insider Buying: BCDA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCDA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies350,8473.08%
Institutions1,489,45613.1%
Individual Insiders2,508,93922.1%
General Public7,025,48261.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 108.6%.

Top Shareholders

Top 25 shareholders own 38.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.24%
Simon Stertzer
823,475US$753.3k15.3%no data
7.03%
Lincoln Alternative Strategies Llc
800,000US$731.8k0%no data
5.59%
Andrew Blank
636,058US$581.9k0%no data
3.36%
Thomas Satterfield
382,650US$350.0k0%no data
3.25%
Peter Altman
369,485US$338.0k34.5%no data
3.08%
A.G. Family L.P.
350,847US$321.0k0%no data
1.14%
CM Management, LLC
130,000US$118.9k0%0.08%
1.1%
Vanguard Capital Management, LLC
124,591US$114.0k0%no data
1%
David McClung
114,245US$104.5k48.6%no data
0.96%
Jim Allen
109,661US$100.3k0%no data
0.83%
Geode Capital Management, LLC
94,287US$86.3k42.9%no data
0.58%
Vanguard Fiduciary Trust Company
66,270US$60.6k0%no data
0.56%
Citadel Advisors LLC
63,384US$58.0k-32.8%no data
0.48%
Edward Gillis
54,126US$49.5k69.8%no data
0.34%
Susquehanna International Group, LLP
38,827US$35.5k0.05%no data
0.31%
Pingora Partners LLC
35,739US$32.7k1,080%0.02%
0.31%
Brown Advisory Incorporated
35,538US$32.5k0%no data
0.21%
XTX Markets Limited
24,270US$22.2k49%no data
0.18%
Virtu Financial, Inc.
20,355US$18.6k0%no data
0.16%
Commonwealth Equity Services, LLC
18,283US$16.7k0%no data
0.13%
Two Sigma Securities, LLC
14,780US$13.5k0%no data
0.12%
Renaissance Technologies LLC
13,900US$12.7k0%no data
0.12%
William Facteau
13,123US$12.0k0%no data
0.032%
Jay Moyes
3,616US$3.3k0%no data
0.027%
Morgan Stanley
3,105US$2.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/12 01:20
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioCardia, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Joseph PantginisH.C. Wainwright & Co.